Isosorbide dinitrate and glucose injection

Isosorbide dinitrate, glucose.

It is suitable for left ventricular failure secondary to acute myocardial infarction, left ventricular failure caused by various causes, and severe or unstable angina pectoris.

The dosage needs to be adjusted according to the patient's response. The normal dosage is 2-7 mg of isosorbide dinitrate per hour, but it can be increased to 10 mg per hour if necessary.

1. Like other nitrate drugs, headache, nausea and tachycardia may occur during the use of this product. 2. Due to the significant decrease in systemic arterial pressure, it may cause cerebral insufficiency and reduced coronary perfusion, but clinical experience shows that the above situation is not common, which is consistent with the fact that the vasodilator effect of this product on the venous system is stronger than that on the arterial system.

1. Patients with known allergy to nitrates. 2. Cardiogenic shock (unless appropriate diastolic blood pressure can be maintained, such as by combining drugs that enhance myocardial contractility). 3. Patients with circulatory failure and severe hypotension. 4. Patients with significant anemia, head trauma, cerebral hemorrhage, severe hypotension or hypovolemia. 5. Combined use of sildenafil (VIAGRA). Sildenafil can significantly enhance the hypotensive effect of isosorbide mononitrate. 6. Patients with glaucoma.

This product may enhance the antihypertensive effect of other antihypertensive drugs. This product may enhance certain effects of alcohol. Taking nitrous oxide donors at the same time, such as the active ingredient in this product and sildenafil (VIAGRA), can significantly enhance the antihypertensive effect of this product.

Keep in dark, airtight, cool place.

100ml: Isosorbide dinitrate 10mg and glucose 5g

Lunan BETTER Pharmaceutical Co., Ltd.

• Founded in:

  2003-12-16

• Address:

  No. 209, Hongqi Road, Linyi City

• Tax NO.:

  91371300756399007K

• Registered Funds:

  115 million yuan

• Website:

  Log in to view

• Email:

  Log in to view